fda glp-1 warning news september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA Approves Orforglipron, First GLP-1

giugno 2023;240(6):137386

The Novel Dihydroorotate Dehydrogenase (DHODH) Inhibitor PTC299 Inhibit De Novo Pyrimidine Synthesis with Broad Anti-Leukemic Activity Against Acute Myeloid Leukemia

GLP-1 receptor agonists are a class of medications that work by mimicking the bodys natural glucagon-like peptide-1 hormone

[2] It is the most abundant and important low-molecular-mass thiol within most cell types

Regulatory Frameworks and Supply Dynamics: In December 2025, the FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill, which launched in January 2026, significantly expanding accessibility for patients averse to injections [3]

When the voltage falls too low the battery can be damaged